l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with Liver Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Makino, I; Nakamura, K; Sato, Y; Terano, A; Yoneda, M | 1 |
1 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and Liver Diseases
Article | Year |
---|---|
Protective effect of central thyrotropin-releasing hormone on carbon tetrachloride-induced acute hepatocellular necrosis in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atropine; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Enzyme Inhibitors; Indomethacin; Injections, Intraventricular; Liver; Liver Diseases; Male; Necrosis; NG-Nitroarginine Methyl Ester; Oxidopamine; Parasympatholytics; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Sympatholytics; Thyrotropin-Releasing Hormone; Vagotomy | 2003 |